SlideShare a Scribd company logo
Challenges in HIV prevention
Presented BY:- Tashfeen Ahmad
ADAM UNIVERSITY SCHOOL OF MEDICINE
8th semester
Content
• Introduction
• Context body
• Conclusion
• References
Introduction
 June 1981 first Case of AIDS.
 past 40 years, 77.3 million HIV
infections
 40.1 million [33.6–48.6 million]
Deaths
 In 2017:-
 < 1 million died of AIDS-related
causes
 about 1.8 million acquired.
 In 2020 :-
 estimated 1.5 million (UI 1.0 to 2.0
million) people acquired HIV
 people living with HIV globally to
37.7 million (UI 30.2 to 45.1 million
Currently, for every two people who
go on treatment for HIV and AIDS,
five People become infected.
Incubation Period
• The interval from HIV infection to the
diagnosis of AIDS ranges from about 9 months
to 20 years or longer, with a median of 12
years.
Failure to implement the strategy
Diagnosis:- 87% in
the Netherlands to 11% in
Yemen
Treatment coverage:- ranged
from 71% in Switzerland to 3%
in Afghanistan
Viral suppression:- 68% in
Switzerland and 7% in China.
Awareness of getting infection
• Nearly one in eight
(approx. 4.8 million people) do
not know they are infected.
Because many new infections
are transmitted by people who
do not know they are infected,
undiagnosed infection remains
a significant factor fueling the
HIV epidemic.
Fear for Testing
• fear and misperceptions can still
keep people from finding out
their HIV status:
• Many people do not believe they
are at risk for HIV infection.
• misunderstand the testing
process,
• concerned that other people will
find out that they sought testing
at all
• avoid testing simply because they
are afraid their test will be
positive.
• Misconception of getting HIV at
diagnostic center
Not Receiving Ongoing Treatment
• treatment coverage ranged
from 71% in Switzerland to
3% in Afghanistan.
• Expensive treatment,
• Lack of social support
• personal capacity to
adhere,
• depression,
• disruptions in daily routine,
• substance use,
• Due to insufficient supply
of antiretroviral therapy or
ART
Low socioeconomic status
• food insufficiency
• Unaffordable ART
• Unsafe sex
• unable to access HIV services
High community rates of HIV
• African Americans and Latinos are at increased
risk of being exposed to HIV infection with each
sexual encounter.
• MSM
• Bisexual male
• More than one sexual partner
• Unprotected sex
• IV Drug abusers
• Reuse of needles
Poor access to health care
• lack consistent health insurance
• Low budget of medical centers
• Less number of HIV centers
• Not diagnostic test for HIV
Limited Resources for HIV Prevention
• Inadequate funds
• Less volunteers for spreading awareness
• Lack of importance from govt. in many countries
• Lack of diagnostic kits
• Insufficient AIDS center
• Insufficient production of contraceptive items
• Lack of injecting materials
• High prices of treatment
Complacent about HIV
• U.S. President Donald
Trump's proposed
reduction in investment
in groundbreaking
organizations fighting
AIDS such as PEPFAR,
• Trump also reportedly
closed down the White
House's Office of National
AIDS Policy in January
2017
• Many don’t consider AIDS
as a disease
Unsafe sex
• MSM
• Anal sex
• Sex workers not getting
tested for HIV
• Less use of
contraceptive
• More than 1 sex
partners
HIV in Pregnancy & Children
Conclusion
• First and foremost is failure to implement of the
strategy so we need to focus on the new
methods to achieve goals.
• Govt. should consider HIV/AIDS a major
problem.
• Spread awareness so more and more people get
to know about HIV/AIDS and its complications.
• Then we need to raise funds for HIV/AIDS
programs and centers to control spread and treat
infected.
• Scaling up production of preventive tools.
References
• Barriers and facilitators of access to HIV prevention, care, and treatment services among people living with HIV in Kerman,
Iran: a qualitative study Zahra Jaafari1, Willi McFarland2, Sana Eybpoosh3, Seyed Vahid Ahmadi Tabatabaei4, Mehdi Shafiei
Bafti5, Ebrahim Ranjbar6 and Hamid Sharifi1*
• World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO.
• World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
• World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health
Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO.
• n Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-
2030. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO.
• Lucie Seyler, BMBCh, DTM&H,Department of Internal Medicine andInfectious Diseases, HIV ReferenceCenter, UZ Brussel,
Laarbeeklaan 101,1090 Brussels, Belgium,phone: +32 2 477 6001,email: lucie.seyler@uzbrussel.beReceived: October 15,
2018.Accepted: October 16, 2018.Published online: October 31, 2018.Conflict of interest: LS, PL, andSDA have participated
in advisoryboards for Gilead, Janssens, MSD,and ViiV Healthcare.Pol Arch Intern Med. 2018;128 (10): 609-
616doi:10.20452/pamw.4357Copyright by Medycyna Praktyczna,Kraków 2018
• Jaafari et al. BMC Health Services Research (2022) 22:1097 https://doi.org/10.1186/s12913-022-08483-4
• Prof Michael H Merson,Duke Global Health Institute,Box 90519, Duke University,Durham, NC 27708, USA
• https://doi.org/10.1016/j.cct.2021.106402
• https://www.hsph.harvard.edu/news/features/progress-challenges-in-tackling-pediatric-hivaids/
QUESTIONS?

More Related Content

What's hot

Proposal Sample for research Armatures/beginners
Proposal Sample for research Armatures/beginnersProposal Sample for research Armatures/beginners
Proposal Sample for research Armatures/beginners
Samuel Trinity
 
Health Equity Strategy into Public Health Action
Health Equity Strategy into Public Health ActionHealth Equity Strategy into Public Health Action
Health Equity Strategy into Public Health Action
Wellesley Institute
 
History of HIV/AIDS
History of HIV/AIDSHistory of HIV/AIDS
History of HIV/AIDS
Wael Alzhrani
 
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
WOREC Nepal
 
Health management information system
Health management information systemHealth management information system
Health management information system
Prakash Ghimire
 
Expanded Programme on Immunization: Poverty & Social Impact Analysis
Expanded Programme on Immunization: Poverty & Social Impact AnalysisExpanded Programme on Immunization: Poverty & Social Impact Analysis
Expanded Programme on Immunization: Poverty & Social Impact Analysis
Sustainable Development Policy Institute
 
Population and its control
Population and its controlPopulation and its control
Population and its control
Kailash Nagar
 
Role of I/NGOs in Health Promotion and Education
Role of I/NGOs in Health Promotion and EducationRole of I/NGOs in Health Promotion and Education
Role of I/NGOs in Health Promotion and Education
Prabesh Ghimire
 
Health System of Nepal
Health System of NepalHealth System of Nepal
Health System of Nepal
S.M. Jashim Uddin Razib
 
2 natural history of hiv and who clinical staging naco lac m
2 natural history of hiv and who clinical staging naco lac m2 natural history of hiv and who clinical staging naco lac m
2 natural history of hiv and who clinical staging naco lac mDrShruthi Pradeep
 
Measuring burden of disease
Measuring burden of diseaseMeasuring burden of disease
Measuring burden of disease
Vikash Keshri
 
BASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDSBASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDS
Md Jahirul Islam Sojib
 
National health policy 2017.pptx
National health policy 2017.pptxNational health policy 2017.pptx
National health policy 2017.pptx
AmruthaNambiar8
 
Public Health Leadership
Public Health LeadershipPublic Health Leadership
Public Health Leadership
Ramya Gokulakannan
 
RNTCP
RNTCP RNTCP
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.comHIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
Sarath Thomas
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health Presentation
Sharanya Rajan
 
Epidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in IrelandEpidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in Ireland
Cian Ó Briain
 

What's hot (20)

Proposal Sample for research Armatures/beginners
Proposal Sample for research Armatures/beginnersProposal Sample for research Armatures/beginners
Proposal Sample for research Armatures/beginners
 
Health Equity Strategy into Public Health Action
Health Equity Strategy into Public Health ActionHealth Equity Strategy into Public Health Action
Health Equity Strategy into Public Health Action
 
History of HIV/AIDS
History of HIV/AIDSHistory of HIV/AIDS
History of HIV/AIDS
 
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
Sexual and Reproductive Health and Rights of Women in Nepal (SRHR)
 
Health management information system
Health management information systemHealth management information system
Health management information system
 
Expanded Programme on Immunization: Poverty & Social Impact Analysis
Expanded Programme on Immunization: Poverty & Social Impact AnalysisExpanded Programme on Immunization: Poverty & Social Impact Analysis
Expanded Programme on Immunization: Poverty & Social Impact Analysis
 
Population and its control
Population and its controlPopulation and its control
Population and its control
 
Lecture 5.cbc
Lecture 5.cbcLecture 5.cbc
Lecture 5.cbc
 
Role of I/NGOs in Health Promotion and Education
Role of I/NGOs in Health Promotion and EducationRole of I/NGOs in Health Promotion and Education
Role of I/NGOs in Health Promotion and Education
 
Health System of Nepal
Health System of NepalHealth System of Nepal
Health System of Nepal
 
2 natural history of hiv and who clinical staging naco lac m
2 natural history of hiv and who clinical staging naco lac m2 natural history of hiv and who clinical staging naco lac m
2 natural history of hiv and who clinical staging naco lac m
 
Measuring burden of disease
Measuring burden of diseaseMeasuring burden of disease
Measuring burden of disease
 
BASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDSBASIC Concept Of HIV/AIDS
BASIC Concept Of HIV/AIDS
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
National health policy 2017.pptx
National health policy 2017.pptxNational health policy 2017.pptx
National health policy 2017.pptx
 
Public Health Leadership
Public Health LeadershipPublic Health Leadership
Public Health Leadership
 
RNTCP
RNTCP RNTCP
RNTCP
 
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.comHIV AIDS & PREVENTION  PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
HIV AIDS & PREVENTION PROGRAMS , BY BR. SARATH THOMAS, sarathcthomas@gmail.com
 
Tuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health PresentationTuberculosis (TB) - Public Health Presentation
Tuberculosis (TB) - Public Health Presentation
 
Epidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in IrelandEpidemiology & impact of Sexually Transmitted Infections in Ireland
Epidemiology & impact of Sexually Transmitted Infections in Ireland
 

Similar to Challenges in HIV prevention.pptx

Challenges in HIV prevention Tashfeen Ahmad.pptx
Challenges in HIV prevention Tashfeen Ahmad.pptxChallenges in HIV prevention Tashfeen Ahmad.pptx
Challenges in HIV prevention Tashfeen Ahmad.pptx
Tashfeen Ahmad
 
HIV AIDS
HIV AIDSHIV AIDS
Planning, implementation and evaluation of education program on HIV/AIDS. .
Planning, implementation and evaluation of education program on HIV/AIDS. .Planning, implementation and evaluation of education program on HIV/AIDS. .
Planning, implementation and evaluation of education program on HIV/AIDS. .
SanjayChaudhary27
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
sirjana Tiwari
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
mZOn2
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
Dr Lipilekha Patnaik
 
Std-2021.pptx
Std-2021.pptxStd-2021.pptx
Std-2021.pptx
sergeipee
 
World aids day 2019
World aids day 2019World aids day 2019
World aids day 2019
Drsnehas2
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
SujitKumarBehera16
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
Sumaiya Akter Snigdha
 
AIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMMEAIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMME
MAHESWARI JAIKUMAR
 
AIDS CONTROL
AIDS CONTROLAIDS CONTROL
AIDS CONTROL
KULDEEP VYAS
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
European Centre for Disease Prevention and Control
 
WORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrongWORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrong
CONSULTANT IN OBGYN, ODISHA ,INDIA
 
AidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notesAidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notes
BincyBinu6
 
WHO Guidelines for Policymakers - World Hepatitis Day 2019
WHO Guidelines for Policymakers - World Hepatitis Day 2019WHO Guidelines for Policymakers - World Hepatitis Day 2019
WHO Guidelines for Policymakers - World Hepatitis Day 2019
Khubaib Samdani
 
HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)
ariannejassy07
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
KritikaDhawan9
 

Similar to Challenges in HIV prevention.pptx (20)

Challenges in HIV prevention Tashfeen Ahmad.pptx
Challenges in HIV prevention Tashfeen Ahmad.pptxChallenges in HIV prevention Tashfeen Ahmad.pptx
Challenges in HIV prevention Tashfeen Ahmad.pptx
 
HIV AIDS
HIV AIDSHIV AIDS
HIV AIDS
 
Planning, implementation and evaluation of education program on HIV/AIDS. .
Planning, implementation and evaluation of education program on HIV/AIDS. .Planning, implementation and evaluation of education program on HIV/AIDS. .
Planning, implementation and evaluation of education program on HIV/AIDS. .
 
Seminar on hiv
Seminar on hivSeminar on hiv
Seminar on hiv
 
seminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdfseminaronhiv-180201064407.pdf
seminaronhiv-180201064407.pdf
 
National AIDS Control Programme
National AIDS Control ProgrammeNational AIDS Control Programme
National AIDS Control Programme
 
Std-2021.pptx
Std-2021.pptxStd-2021.pptx
Std-2021.pptx
 
World aids day 2019
World aids day 2019World aids day 2019
World aids day 2019
 
AIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptxAIDS and Global health diplomacy.pptx
AIDS and Global health diplomacy.pptx
 
Gender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girlsGender dimension of HIV/AIDS among young girls
Gender dimension of HIV/AIDS among young girls
 
AIDS
AIDSAIDS
AIDS
 
AIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMMEAIDS CONTROL PROGRAMME
AIDS CONTROL PROGRAMME
 
AIDS CONTROL
AIDS CONTROLAIDS CONTROL
AIDS CONTROL
 
What Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIVWhat Works? – more than 30 years of prevention and control of HIV
What Works? – more than 30 years of prevention and control of HIV
 
WORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrongWORLD AIDS DAY 2015 ,Where we went wrong
WORLD AIDS DAY 2015 ,Where we went wrong
 
AidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notesAidsNACP 2.pptx 4th year community health aids notes
AidsNACP 2.pptx 4th year community health aids notes
 
HIV/AIDS in sudan
HIV/AIDS in sudanHIV/AIDS in sudan
HIV/AIDS in sudan
 
WHO Guidelines for Policymakers - World Hepatitis Day 2019
WHO Guidelines for Policymakers - World Hepatitis Day 2019WHO Guidelines for Policymakers - World Hepatitis Day 2019
WHO Guidelines for Policymakers - World Hepatitis Day 2019
 
HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)HIV in the Philippines (esp. cebu)
HIV in the Philippines (esp. cebu)
 
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxNATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptx
 

More from Tashfeen Ahmad

pericardium.pptx
pericardium.pptxpericardium.pptx
pericardium.pptx
Tashfeen Ahmad
 
Cognitive dissonance
Cognitive dissonanceCognitive dissonance
Cognitive dissonance
Tashfeen Ahmad
 
Mitosis , Cell division
Mitosis , Cell divisionMitosis , Cell division
Mitosis , Cell division
Tashfeen Ahmad
 
Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.ppt
Tashfeen Ahmad
 
Nanopore sequencing .
Nanopore sequencing .Nanopore sequencing .
Nanopore sequencing .
Tashfeen Ahmad
 
Nanopore Sequencing
Nanopore SequencingNanopore Sequencing
Nanopore Sequencing
Tashfeen Ahmad
 
Yellow fever
Yellow feverYellow fever
Yellow fever
Tashfeen Ahmad
 
Glycolysis biochemistry
Glycolysis biochemistryGlycolysis biochemistry
Glycolysis biochemistry
Tashfeen Ahmad
 

More from Tashfeen Ahmad (8)

pericardium.pptx
pericardium.pptxpericardium.pptx
pericardium.pptx
 
Cognitive dissonance
Cognitive dissonanceCognitive dissonance
Cognitive dissonance
 
Mitosis , Cell division
Mitosis , Cell divisionMitosis , Cell division
Mitosis , Cell division
 
Medication administration.ppt
Medication administration.pptMedication administration.ppt
Medication administration.ppt
 
Nanopore sequencing .
Nanopore sequencing .Nanopore sequencing .
Nanopore sequencing .
 
Nanopore Sequencing
Nanopore SequencingNanopore Sequencing
Nanopore Sequencing
 
Yellow fever
Yellow feverYellow fever
Yellow fever
 
Glycolysis biochemistry
Glycolysis biochemistryGlycolysis biochemistry
Glycolysis biochemistry
 

Recently uploaded

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 

Recently uploaded (20)

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 

Challenges in HIV prevention.pptx

  • 1. Challenges in HIV prevention Presented BY:- Tashfeen Ahmad ADAM UNIVERSITY SCHOOL OF MEDICINE 8th semester
  • 2. Content • Introduction • Context body • Conclusion • References
  • 3. Introduction  June 1981 first Case of AIDS.  past 40 years, 77.3 million HIV infections  40.1 million [33.6–48.6 million] Deaths  In 2017:-  < 1 million died of AIDS-related causes  about 1.8 million acquired.  In 2020 :-  estimated 1.5 million (UI 1.0 to 2.0 million) people acquired HIV  people living with HIV globally to 37.7 million (UI 30.2 to 45.1 million Currently, for every two people who go on treatment for HIV and AIDS, five People become infected.
  • 4.
  • 5. Incubation Period • The interval from HIV infection to the diagnosis of AIDS ranges from about 9 months to 20 years or longer, with a median of 12 years.
  • 6. Failure to implement the strategy Diagnosis:- 87% in the Netherlands to 11% in Yemen Treatment coverage:- ranged from 71% in Switzerland to 3% in Afghanistan Viral suppression:- 68% in Switzerland and 7% in China.
  • 7. Awareness of getting infection • Nearly one in eight (approx. 4.8 million people) do not know they are infected. Because many new infections are transmitted by people who do not know they are infected, undiagnosed infection remains a significant factor fueling the HIV epidemic.
  • 8. Fear for Testing • fear and misperceptions can still keep people from finding out their HIV status: • Many people do not believe they are at risk for HIV infection. • misunderstand the testing process, • concerned that other people will find out that they sought testing at all • avoid testing simply because they are afraid their test will be positive. • Misconception of getting HIV at diagnostic center
  • 9. Not Receiving Ongoing Treatment • treatment coverage ranged from 71% in Switzerland to 3% in Afghanistan. • Expensive treatment, • Lack of social support • personal capacity to adhere, • depression, • disruptions in daily routine, • substance use, • Due to insufficient supply of antiretroviral therapy or ART
  • 10. Low socioeconomic status • food insufficiency • Unaffordable ART • Unsafe sex • unable to access HIV services
  • 11. High community rates of HIV • African Americans and Latinos are at increased risk of being exposed to HIV infection with each sexual encounter. • MSM • Bisexual male • More than one sexual partner • Unprotected sex • IV Drug abusers • Reuse of needles
  • 12. Poor access to health care • lack consistent health insurance • Low budget of medical centers • Less number of HIV centers • Not diagnostic test for HIV
  • 13. Limited Resources for HIV Prevention • Inadequate funds • Less volunteers for spreading awareness • Lack of importance from govt. in many countries • Lack of diagnostic kits • Insufficient AIDS center • Insufficient production of contraceptive items • Lack of injecting materials • High prices of treatment
  • 14. Complacent about HIV • U.S. President Donald Trump's proposed reduction in investment in groundbreaking organizations fighting AIDS such as PEPFAR, • Trump also reportedly closed down the White House's Office of National AIDS Policy in January 2017 • Many don’t consider AIDS as a disease
  • 15. Unsafe sex • MSM • Anal sex • Sex workers not getting tested for HIV • Less use of contraceptive • More than 1 sex partners
  • 16. HIV in Pregnancy & Children
  • 17. Conclusion • First and foremost is failure to implement of the strategy so we need to focus on the new methods to achieve goals. • Govt. should consider HIV/AIDS a major problem. • Spread awareness so more and more people get to know about HIV/AIDS and its complications. • Then we need to raise funds for HIV/AIDS programs and centers to control spread and treat infected. • Scaling up production of preventive tools.
  • 18. References • Barriers and facilitators of access to HIV prevention, care, and treatment services among people living with HIV in Kerman, Iran: a qualitative study Zahra Jaafari1, Willi McFarland2, Sana Eybpoosh3, Seyed Vahid Ahmadi Tabatabaei4, Mehdi Shafiei Bafti5, Ebrahim Ranjbar6 and Hamid Sharifi1* • World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. • World health statistics 2022: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. • World health statistics 2019: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. • n Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022- 2030. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. • Lucie Seyler, BMBCh, DTM&H,Department of Internal Medicine andInfectious Diseases, HIV ReferenceCenter, UZ Brussel, Laarbeeklaan 101,1090 Brussels, Belgium,phone: +32 2 477 6001,email: lucie.seyler@uzbrussel.beReceived: October 15, 2018.Accepted: October 16, 2018.Published online: October 31, 2018.Conflict of interest: LS, PL, andSDA have participated in advisoryboards for Gilead, Janssens, MSD,and ViiV Healthcare.Pol Arch Intern Med. 2018;128 (10): 609- 616doi:10.20452/pamw.4357Copyright by Medycyna Praktyczna,Kraków 2018 • Jaafari et al. BMC Health Services Research (2022) 22:1097 https://doi.org/10.1186/s12913-022-08483-4 • Prof Michael H Merson,Duke Global Health Institute,Box 90519, Duke University,Durham, NC 27708, USA • https://doi.org/10.1016/j.cct.2021.106402 • https://www.hsph.harvard.edu/news/features/progress-challenges-in-tackling-pediatric-hivaids/
  • 19.